Form 4: Cardio Diagnostics Director Acquires Stock Options

Cardio Diagnostics Holdings Director Peter K Fung acquired 2,306 stock options with an exercise price of $2.71, effective December 31, 2025.

Summary

• Peter K Fung, a Director of Cardio Diagnostics Holdings, Inc. (CDIO), acquired 2,306 stock options.
• The stock options have an exercise price of $2.71 per share.
• The transaction date for these options was December 31, 2025.
• The options become exercisable on December 31, 2025, and are set to expire on December 31, 2035.
• Following this transaction, Peter K Fung beneficially owns a total of 6,308 derivative securities (stock options).

Sentiment

Score: 6

Explanation: The acquisition of stock options by a director is generally viewed as a neutral to slightly positive signal, indicating management's alignment with shareholder interests and potential confidence in future stock price appreciation. However, it does not provide direct insight into the company's operational or financial performance.

Positives

• A director acquiring stock options can signal confidence in the company's future performance and aligns management's interests with those of shareholders.
• The options have a 10-year expiration date, providing a long-term incentive for the director.

Risks

• The value of the stock options is contingent on the future stock price of Cardio Diagnostics Holdings, Inc. exceeding the exercise price of $2.71.
• Market volatility and company-specific performance could negatively impact the potential profitability of these options.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports an insider transaction.

Industry Context

This filing is a standard insider transaction report and does not provide information to analyze broader industry trends or competitor comparisons. It reflects an individual director's equity compensation and ownership.

Comparison to Industry Standards

• This filing does not provide sufficient information to assess results against global benchmarks or specific comparable companies or projects. It is a disclosure of an individual's equity compensation.

Related Party Transactions

• The acquisition of stock options by a director (Peter K Fung) from the issuer (Cardio Diagnostics Holdings, Inc.) represents a transaction between a related party and the company, which is a common form of executive compensation.

Stakeholder Impact

• Shareholders: May view the director's acquisition of options as a positive signal of confidence in the company's future, potentially aligning management's interests with their own.

Key Dates

Keywords

Cardio Diagnostics Holdings, Inc., CDIO, Form 4, Insider Transaction, Stock Options, Director Compensation, Beneficial Ownership, Equity Grant